Hedge FundsManager News

Tiger grand cub D1 finances medical device company

D1 Capital Partners led the latest financing round totaling $30 million for Silicon Valley medical device company Sight Sciences. Proceeds from the Series E Preferred Stock financing round will be used for continued clinical and operational development and to support commercial expansion for Sight Sciences OMNI and TearCare products catering to eye disease treatment. “In …

GET THE FULL STORY

Continue reading this article with an annual or monthly subscription. One low price gets you instant access to:

  • All new and archived articles
  • Mandate charts
  • Daily, weekly & monthly newsletters

Start Reading

Tags

Related Articles

Back to top button
Close